We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Testing the Helpfulness of 2 Decision Aids for Prostate Cancer

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00432601
First Posted: February 8, 2007
Last Update Posted: March 22, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
VA Office of Research and Development
Results First Submitted: March 19, 2015  
Study Type: Interventional
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: None (Open Label)
Condition: Prostate Cancer
Intervention: Behavioral: type of decision aid

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Arm 1 - MCC

Patients will receive Michigan Cancer Consortium decision aid.

type of decision aid: We will be comparing two decision aids (MCC vs. NCCN) in terms of their impact on decision making and patient-physician communication.

Arm 2 - NCCN

Patients will receive National Comprehensive Cancer Network decision aid.

type of decision aid: We will be comparing two decision aids (MCC vs. NCCN) in terms of their impact on decision making and patient-physician communication.


Participant Flow for 2 periods

Period 1:   Time 1 to Time 2
    Arm 1 - MCC   Arm 2 - NCCN
STARTED   510   512 
COMPLETED   141 [1]   144 [1] 
NOT COMPLETED   369   368 
[1] There is large drop-off as only one-third of subjects enrolled were eligible to continue the study

Period 2:   Time 2 to Time 3
    Arm 1 - MCC   Arm 2 - NCCN
STARTED   141   144 
COMPLETED   122   122 
NOT COMPLETED   19   22 



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Arm 1

Patients will receive Michigan Cancer Consortium decision aid.

type of decision aid: We will be comparing two decision aids (MCC vs. NCCN) in terms of their impact on decision making and patient-physician communication.

Arm 2

Patients will receive National Comprehensive Cancer Network decision aid.

type of decision aid: We will be comparing two decision aids (MCC vs. NCCN) in terms of their impact on decision making and patient-physician communication.

Total Total of all reporting groups

Baseline Measures
   Arm 1   Arm 2   Total 
Overall Participants Analyzed 
[Units: Participants]
 510   512   1022 
Age 
[Units: Years]
Mean (Standard Deviation)
 63.41  (5.86)   63.14  (6.02)   63.28  (5.94) 
Gender 
[Units: Participants]
     
Female   0   0   0 
Male   510   512   1022 


  Outcome Measures

1.  Primary:   Knowledge   [ Time Frame: Results visit (Time 2 - approximately 7-10 days after Time 1) ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.


Results Point of Contact:  
Name/Title: Dr. Angela Fagerlin
Organization: VA HSRD
phone: 801-587-1694
e-mail: angie.fagerlin@hsc.utah.edu


Publications of Results:

Responsible Party: VA Office of Research and Development
ClinicalTrials.gov Identifier: NCT00432601     History of Changes
Other Study ID Numbers: IIR 05-283
First Submitted: February 6, 2007
First Posted: February 8, 2007
Results First Submitted: March 19, 2015
Results First Posted: March 22, 2016
Last Update Posted: March 22, 2016



To Top